numares news: numares appoints Winton Gibbons, as new president of its US subsidiary, Numares Health
We develop improved diagnostic testing for conditions related to metabolic dysfunction, including chronic kidney, liver and cardiac diseases.
From a single serum sample, we quantify multiple biomarkers — known and newly discovered. Precision Diagnostics.
Using FDA-cleared technology, this is our core platform. It incorporates diagnostic testing algorithms into nuclear magnetic resonance (NMR) spectroscopy. It's the first modular software-based system for clinical diagnostics.